Inflammatory cytokine networks

Inflammatory cytokine networks consist of a highly sophisticated and redundant system of low-molecular-weight proteins that facilitate communication between cells of the immune system and other tissues (Zhang & An, 2007, PubMed). These networks are characterized by pleiotropy and redundancy, where a single cytokine can exert multiple effects and different cytokines can perform similar functions to ensure a robust immune response (Dinarello, 2000, Chest). In healthy states, these networks maintain homeostasis by balancing pro-inflammatory and anti-inflammatory signals; however, persistent activation or dysregulation leads to chronic inflammatory and autoimmune disorders such as rheumatoid arthritis and psoriasis (Kopitar-Jerala, 2017, Frontiers in Immunology). Pharmacological targeting of these networks has revolutionized the treatment of inflammatory diseases through the use of biologics that specifically inhibit key nodes like Tumor necrosis factor-alpha, Interleukin-6, or Interleukin-17 (Feldmann, 2002, Nature Reviews Immunology). Despite their efficacy, these interventions require careful monitoring due to the risk of serious infections and other immune-related adverse events resulting from the broad suppression of host defense mechanisms (Schett et al., 2013, Nature Medicine).

Other names

Cytokine signaling pathwaysPro-inflammatory cytokine cascadeCytokine milieuInflammatory signaling network

Therapeutic strategies involve the neutralization of soluble ligands, competitive inhibition of cell-surface receptors, or the inhibition of intracellular signaling pathways such as the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway to dampen the inflammatory cascade (Dinarello, 2011, Blood; Feldmann, 2002, Nature Reviews Immunology).